Marijke Buijze

590 total citations
14 papers, 427 citations indexed

About

Marijke Buijze is a scholar working on Otorhinolaryngology, Oncology and Molecular Biology. According to data from OpenAlex, Marijke Buijze has authored 14 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Otorhinolaryngology, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Marijke Buijze's work include Head and Neck Cancer Studies (9 papers), Cancer-related Molecular Pathways (6 papers) and Oral Health Pathology and Treatment (4 papers). Marijke Buijze is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Cancer-related Molecular Pathways (6 papers) and Oral Health Pathology and Treatment (4 papers). Marijke Buijze collaborates with scholars based in Netherlands, United States and United Kingdom. Marijke Buijze's co-authors include Ruud H. Brakenhoff, Boudewijn J.M. Braakhuis, C. René Leemans, Elisabeth Bloemena, Sanne R. Martens‐de Kemp, Dirk J. Kuik, Remco Nagel, Marijke Stigter‐van Walsum, Arjen Brink and Peter J.F. Snijders and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Marijke Buijze

14 papers receiving 422 citations

Peers

Countries citing papers authored by Marijke Buijze

Since Specialization

Citations

This map shows the geographic impact of Marijke Buijze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijke Buijze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijke Buijze more than expected).

Fields of papers citing papers by Marijke Buijze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijke Buijze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijke Buijze. The network helps show where Marijke Buijze may publish in the future.

Co-authorship network of co-authors of Marijke Buijze

This figure shows the co-authorship network connecting the top 25 collaborators of Marijke Buijze. A scholar is included among the top collaborators of Marijke Buijze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marijke Buijze. Marijke Buijze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients 2024 ·Oncogenesis ·(unknown), (unknown), (unknown), Marijke Buijze, Maaike Kreft, Ji‐Ying Song, (unknown), Heinz Jacobs, Ruud H. Brakenhoff	1
2	Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation 2024 ·Cells ·Leon J. Wils, Marijke Buijze, Marijke Stigter‐van Walsum, Arjen Brink, (unknown), Laura A. N. Peferoen, (unknown), (unknown), E.H. van der Meij, Elisabeth Bloemena, Jos B. Poell, Ruud H. Brakenhoff	1
3	Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition 2020 ·Scientific Reports ·(unknown), (unknown), Sanne R. Martens‐de Kemp, Marijke Buijze, (unknown), Keith D. Hunter, C. René Leemans, Victor W. van Beusechem, Rob M.F. Wolthuis, Renée X. de Menezes, Ruud H. Brakenhoff	11
4	Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death 2019 ·Oncogenesis ·(unknown), Marijke Buijze, (unknown), Martin A. Rooimans, Sanne R. Martens‐de Kemp, Costa Bachas, Arjen Brink, Marijke Stigter‐van Walsum, Rob M.F. Wolthuis, Ruud H. Brakenhoff	46
5	Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass 2019 ·Oral Oncology ·(unknown), Jos B. Poell, Marijke Buijze, Arjen Brink, Susanne I. Wells, C. René Leemans, Rob M.F. Wolthuis, Ruud H. Brakenhoff	21
6	Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining 2018 ·Molecular Cancer Research ·(unknown), Arjen Brink, Marijke Buijze, Marijke Stigter‐van Walsum, Keith D. Hunter, Bauke Ylstra, Elisabeth Bloemena, C. René Leemans, Ruud H. Brakenhoff	24
7	Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck 2017 ·Oncotarget ·(unknown), Sanne R. Martens‐de Kemp, Marijke Buijze, Marijke Stigter‐van Walsum, Elisabeth Bloemena, Ralf Dietrich, C. René Leemans, Victor W. van Beusechem, Boudewijn J.M. Braakhuis, Ruud H. Brakenhoff	20
8	Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC 2015 ·Molecular Cancer Therapeutics ·Remco Nagel, Marijke Stigter‐van Walsum, Marijke Buijze, Jaap van den Berg, (unknown), (unknown), Sander R. Piersma, Thang V. Pham, Connie R. Jiménez, Victor W. van Beusechem, Ruud H. Brakenhoff	32
9	Noninvasive Molecular Screening for Oral Precancer in Fanconi Anemia Patients 2015 ·Cancer Prevention Research ·(unknown), Eunike Velleuer, Ralf Dietrich, (unknown), Arjen Brink, Marijke Buijze, Dorly J. H. Deeg, Jean Soulier, C. René Leemans, Boudewijn J.M. Braakhuis, Ruud H. Brakenhoff	15
10	Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines 2013 ·Oral Oncology ·Remco Nagel, Sanne R. Martens‐de Kemp, Marijke Buijze, (unknown), Boudewijn J.M. Braakhuis, Ruud H. Brakenhoff	62
11	TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients 2013 ·Oral Diseases ·(unknown), M.M. Rietbergen, Marijke Buijze, PJF Snijders, Elisabeth Bloemena, (unknown), C. René Leemans	26
12	Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma 2011 ·Clinical Cancer Research ·(unknown), Ruud H. Brakenhoff, Dirk J. Kuik, Marijke Buijze, Elisabeth Bloemena, Peter J.F. Snijders, C. René Leemans, Boudewijn J.M. Braakhuis	66
13	Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma 2010 ·International Journal of Cancer ·(unknown), Paweł Golusiński, Marijke Buijze, (unknown), (unknown), Dirk J. Kuik, Elisabeth Bloemena, C. René Leemans, Ruud H. Brakenhoff, Boudewijn J.M. Braakhuis	41
14	Differential Proteomics Identifies Protein Biomarkers That Predict Local Relapse of Head and Neck Squamous Cell Carcinomas 2009 ·Clinical Cancer Research ·Tieneke B.M. Schaaij‐Visser, (unknown), Sharon Gauci, Boudewijn J.M. Braakhuis, Marijke Buijze, Albert J. R. Heck, Dirk J. Kuik, Elisabeth Bloemena, C. René Leemans, Monique Slijper, Ruud H. Brakenhoff	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact